An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients
Jing-Zhang Wang, Rui-Ying Zhang, Jing Bai, Jing-Zhang Wang, Rui-Ying Zhang, Jing Bai
No abstract availableKeywords: Antioxidant; Antiviral immunity; COVID-19; Cardiac injury; Reactive oxygen species.
Conflict of interest statement
Declaration of competing interest None.
References
- Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China, Lancet. 2020;395:497–506.
- Loffredo L., Martino F., Zicari A.M., Carnevale R., Battaglia S., Martino E. Enhanced NOX-2 derived oxidative stress in offspring of patients with early myocardial infarction. Int. J. Cardiol. 2019;293:56–59.
- Perrone L.A., Belser J.A., Wadford D.A., Katz J.M., Tumpey T.M. Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice. J. Infect. Dis. 2013;207:1576–1584.
- Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235–249.
- Erol N., Saglam L., Saglam Y.S., Erol H.S., Altun S., Aktas M.S. The protection potential of antioxidant vitamins against acute respiratory distress syndrome: a rat trial. Inflammation. 2019;42:1585–1594.
Source: PubMed